DeepCure

DeepCure is developing a computational drug discovery platform to improve the breadth and accuracy of preclinical drug development, saving up to 80% of preclinical time and cost. DeepCure’s algorithms analyze a trillion drug candidates from its proprietary virtual library, identifying highly effective drugs that are un

DeepCure operates in artificial intelligence based in Boston, Massachusetts, US, founded in 2018.

Profile

DeepCure is developing a computational drug discovery platform to improve the breadth and accuracy of preclinical drug development, saving up to 80% of preclinical time and cost. DeepCure’s algorithms analyze a trillion drug candidates from its proprietary virtual library, identifying highly effective drugs that are unlikely to be discovered by the conventional drug discovery pipeline.

As a business in artificial intelligence, DeepCure is listed here with the public details available about it.

Boston, Massachusetts, US is where the company is located.

It is recorded at the Creative Destruction Lab alumni company stage.

Its team size is recorded as 11-50 employees.

Website: deepcure.ai